Current antiaging strategies focusing on druggable targets have met with relatively limited success to date. Replacement of cells, tissues, and organs could provide an alternative means for targeting age-induced damage and potentially eliminating some of it. However, before this is a viable option, numerous challenges need to be addressed. Most notably, whether the brain, which defines our self-identity, is amenable to replacement therapies is unclear. Here, we consider whether progressive cell replacement is a potential approach to reverse brain aging without grossly altering function. We focus mainly on the neocortex, seat of our highest cognitive functions, because of abundant knowledge on neocortical development, plasticity, and how the neocortex can functionally incorporate new neurons. We outline the primary challenges for brain cell replacement, and key areas that require further investigation.
*
Current antiaging strategies focusing on druggable targets have met with relatively limited success to date. Replacement of cells, tissues, and organs could provide an alternative means for targeting age-induced damage and potentially eliminating some of it. However, before this is a viable option, numerous challenges need to be addressed. Most notably, whether the brain, which defines our self-identity, is amenable to replacement therapies is unclear. Here, we consider whether progressive cell replacement is a potential approach to reverse brain aging without grossly altering function. We focus mainly on the neocortex, seat of our highest cognitive functions, because of abundant knowledge on neocortical development, plasticity, and how the neocortex can functionally incorporate new neurons. We outline the primary challenges for brain cell replacement, and key areas that require further investigation.
Limitations to Pharmacological Approaches for Slowing Age-Related Damage
The research community and, more recently, biotech companies have begun taking the first steps toward identifying molecular targets for pharmaceuticals that could have, if not systemic, at least broad antiaging benefits. Sometimes referred to as 'geroscience', this new area of research in aging originates, in part, from observations that dietary restriction (DR) or reduced somatotropic signaling results in improved life span and health span [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] . The effects of dampening growth signaling can be mimicked by drugs, with several geroprotective compounds (e.g., rapamycin) demonstrated to have beneficial impact on multiple age-related phenotypes [13, 14] .
Some geroprotectors, including rapamycin, also appeared to increase maximal life span in mice [15] . However, while geroscience approaches are likely to improve health span in elderly humans -and curtail certain life-shortening factors -an effect on human maximal life span is doubtful. It should be realized that results suggesting an effect on maximal life span all come from work with short-lived laboratory animals, and it is not clear whether these effects can be extrapolated to humans -perhaps not even to the species being studied when in the wild. Indeed, DR's effect on longevity in rodent studies depends, at least to some extent, on the control group being obese, and an increase in longevity is not shared by all genotypes, with no evidence that either DR or any geroprotective compound yet studied increases longevity beyond the maximum species life span [16] . Importantly, DR appears to have no effect, or only small effects, on life span in non-human primates, although there is no doubt about its positive effects on health span [17, 18] . The tremendous complexity of age-related damage may underlie the limitations of DR and mimetic drugs (Box 1).
In addition to drugs that might target metabolism, drugs that target the functionality of aged stem cells, such as 'youthful' factors in the blood of young animals [19, 20] , while possibly
Research on aging has recently surged, with a primary focus on developing druggable targets for interventions.
To date, drug-based approaches have shown evidence of enhancing health in old age, but without clear evidence for extending maximal life span.
Progress in cell, tissue, and organ replacements is providing -at least in principle -an alternative to pharmacological approaches that could undo age-related damage. However, whether cell replacement is also applicable to the brain, due to possible loss of self-identity, is an open question.
Recent breakthroughs in brain-cell transplant studies show that new neurons can integrate in the adult neocortex, suggesting that, combined with normal plasticity, progressive cell replacements are possible.
While major challenges remain, rejuvenation of the brain via cell replacement to reverse age-related damage and functional decline appears to be as valid an approach as it is for most other organs and tissues.
